Results 131 to 140 of about 1,619,190 (169)
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort. [PDF]
PLoS One, 2016 Foster GR, Coppola C, Derbala M, Ferenci P, Orlandini A, Reddy KR, Tallarico L, Shiffman ML, Ahlers S, Bakalos G, Hassanein T, GUARD-C Study Group. +11 moreeuropepmc +1 more sourceAt-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods. [PDF]
Sci RepMesinovic M, Wong XC, Rajahram GS, Citarella BW, Peariasamy KM, van Someren Greve F, Olliaro P, Merson L, Clifton L, Kartsonaki C, ISARIC Characterisation Group. +10 moreeuropepmc +1 more sourceISARIC COVID-19 Clinical Data Report: Final report January 2020 – January 2023
, 2020 ISARIC Clinical Characterisation Group, Baillie JK, Baruch J, Beane A, Blumberg L, Bozza FA, Broadley T, Broadley T, Burrell A, Burrell A, Carson G, Citarella BW, Dunning J, Elotmani L, Garcia Barrio N, Garcia Barrio N, Goffard J, Hall M, Hall M, Hashmi M, Horby P, Jassat W, Kartsonaki C, Kumar Tirupakuzhi Vijayaraghavan B, Kumar Vecham P, Laouenan C, Lissauer S, Lissauer S, Martin-Loeches I, Martin-Loeches I, Mentre F, Morton B, Munblit D, Nekliudov NA, Nichol A, Ong DS, Panda PK, Jimenez MP, Petrovic M, Ramakrishnan N, Ramos GV, Roger C, Rojek A, Sandulescu O, Semple MG, Sharma P, Shrapnel S, Sigfrid L, Sim Lim Heng B, Singh BC, Somers E, Streinu-Cercel A, Taccone FS, Wei J, Wils E, Wong XC, Young K, Olliaro PL, Merson L. +58 moreeuropepmc +1 more source